Trial Profile
Assessment of safety and efficacy of biphasic human insulin IU 100 to EX1000 on glycaemic control in subjects with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs EX 1000 (Primary) ; Insulin suspension isophane/insulin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 13 Sep 2012 Planned number of patients changed from 400 to 480.
- 25 Aug 2011 New source identified and integrated (Clinical Trial Registry - India, CTRI2008-091-000035).
- 25 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.